Becton, Dickinson and Company (0R19.L)
USD 206.5
(4.35%)
USD 206.5
(4.35%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 14.46 Billion USD | -2.69% |
| 2022 | 15.4 Billion USD | -1.78% |
| 2021 | 15.68 Billion USD | 1.5% |
| 2020 | 15.45 Billion USD | -17.79% |
| 2019 | 18.8 Billion USD | -7.2% |
| 2018 | 20.25 Billion USD | 331.87% |
| 2017 | 4.69 Billion USD | -53.14% |
| 2016 | 10.01 Billion USD | -12.18% |
| 2015 | 11.39 Billion USD | 440.19% |
| 2014 | 2.11 Billion USD | 1.44% |
| 2013 | 2.08 Billion USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 14.87 Billion USD | -0.36% |
| 2024 Q3 | 14.86 Billion USD | -4.82% |
| 2024 Q2 | 15.61 Billion USD | 4.98% |
| 2023 Q1 | 15.71 Billion USD | 1.97% |
| 2023 Q4 | 14.92 Billion USD | -5.26% |
| 2023 FY | 14.92 Billion USD | -3.11% |
| 2023 Q3 | 15.75 Billion USD | -2.46% |
| 2023 Q2 | 16.15 Billion USD | 2.83% |
| 2022 FY | 15.4 Billion USD | -1.78% |
| 2022 Q3 | 13.6 Billion USD | -11.17% |
| 2022 Q4 | 15.4 Billion USD | 13.25% |
| 2022 Q2 | 15.31 Billion USD | -0.4% |
| 2022 Q1 | 15.37 Billion USD | -1.98% |
| 2021 FY | 15.68 Billion USD | 1.5% |
| 2021 Q3 | 14.45 Billion USD | 3.34% |
| 2021 Q1 | 14.57 Billion USD | -5.64% |
| 2021 Q2 | 13.98 Billion USD | -4.02% |
| 2021 Q4 | 15.68 Billion USD | 8.55% |
| 2020 FY | 15.45 Billion USD | -17.79% |
| 2020 Q4 | 15.44 Billion USD | -4.54% |
| 2020 Q2 | 19.16 Billion USD | -0.13% |
| 2020 Q3 | 16.17 Billion USD | -15.57% |
| 2020 Q1 | 19.18 Billion USD | 1.76% |
| 2019 FY | 18.8 Billion USD | -7.2% |
| 2019 Q4 | 18.85 Billion USD | -4.1% |
| 2019 Q2 | 19.92 Billion USD | -1.0% |
| 2019 Q3 | 19.66 Billion USD | -1.33% |
| 2019 Q1 | 20.12 Billion USD | -1.12% |
| 2018 FY | 20.25 Billion USD | 331.87% |
| 2018 Q4 | 20.35 Billion USD | -2.45% |
| 2018 Q3 | 20.86 Billion USD | -3.13% |
| 2018 Q2 | 21.54 Billion USD | -0.62% |
| 2018 Q1 | 21.67 Billion USD | 362.03% |
| 2017 Q1 | 10.09 Billion USD | 0.7% |
| 2017 Q2 | 9.76 Billion USD | -3.33% |
| 2017 Q3 | 5.16 Billion USD | -47.1% |
| 2017 Q4 | 4.69 Billion USD | -9.16% |
| 2017 FY | 4.69 Billion USD | -53.14% |
| 2016 Q1 | 11.22 Billion USD | -1.51% |
| 2016 FY | 10.01 Billion USD | -12.18% |
| 2016 Q4 | 10.02 Billion USD | -2.12% |
| 2016 Q3 | 10.24 Billion USD | -5.33% |
| 2016 Q2 | 10.82 Billion USD | -3.6% |
| 2015 Q2 | 11.92 Billion USD | 644.44% |
| 2015 Q1 | 1.6 Billion USD | -24.08% |
| 2015 Q3 | 11.61 Billion USD | -2.63% |
| 2015 Q4 | 11.39 Billion USD | -1.84% |
| 2015 FY | 11.39 Billion USD | 440.19% |
| 2014 Q1 | 2.29 Billion USD | 10.1% |
| 2014 FY | 2.11 Billion USD | 1.44% |
| 2014 Q2 | 2.23 Billion USD | -2.4% |
| 2014 Q3 | 2.31 Billion USD | 3.45% |
| 2014 Q4 | 2.11 Billion USD | -8.74% |
| 2013 Q2 | 2.14 Billion USD | 211.9% |
| 2013 Q3 | 2 Billion USD | -6.42% |
| 2013 Q4 | 2.08 Billion USD | 3.59% |
| 2013 Q1 | -1.91 Billion USD | 0.0% |
| 2013 FY | 2.08 Billion USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 19246.908% |
| Accuray Incorporated | 103.58 Million USD | -13862.312% |
| Align Technology, Inc. | -840.47 Million USD | 1820.823% |
| Elevance Health Inc. | 18.59 Billion USD | 22.217% |
| AxoGen, Inc. | 32.26 Million USD | -44724.273% |
| Boston Scientific Corporation | 8.23 Billion USD | -75.692% |
| CVS Health Corporation | 71.18 Billion USD | 79.684% |
| Cardinal Health, Inc. | 476 Million USD | -2938.445% |
| Centene Corporation | 506 Million USD | -2758.3% |
| DaVita Inc. | 10.65 Billion USD | -35.78% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 64.659% |
| Hologic, Inc. | 374.4 Million USD | -3762.981% |
| Humana Inc. | 5.51 Billion USD | -162.058% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -2828.041% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | -166.973% |
| Masimo Corporation | 804 Million USD | -1698.881% |
| McKesson Corporation | 889 Million USD | -1526.884% |
| Patterson Companies, Inc. | 648.47 Million USD | -2130.299% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | -208.84% |
| ResMed Inc. | 635.57 Million USD | -2175.581% |
| Henry Schein, Inc. | 2.57 Billion USD | -462.763% |
| Teladoc Health, Inc. | 468.6 Million USD | -2986.414% |
| Universal Health Services, Inc. | 5.24 Billion USD | -175.633% |
| Veeva Systems Inc. | -647.71 Million USD | 2332.937% |
| Baxter International Inc. | 11.16 Billion USD | -29.527% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 643.66% |
| Danaher Corporation | 13.49 Billion USD | -7.197% |
| Stryker Corporation | 10.02 Billion USD | -44.284% |
| Medtronic plc | 23.67 Billion USD | 38.921% |